Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-26

Clinical Trial Update: Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for INFECTOSCAB 5% (Permethrin) in treating scabies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFECTOSCAB 5% (Permethrin) (Permethrin)

Snippet

Sponsor: Infectopharm Arzneimittel GmbH | Conditions: Scabies | Phase 3 | Status: UNKNOWN